Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK) HKSE
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
40603
First IPO Date
October 30, 2012
Key Executives
| Name | Title | Pay | Year Born |
| Yi Liu | President, CEO, Chair of Fosun MedTech, Co-Chair of Innovative Medicines Division & Exec Director | 0 | 1975 |
| Wang Xingli | Co-President & CEO of the Innovative Drugs Business Unit | 0 | 1962 |
| Wenjie Zhang | Co-President & Co-CEO of Innovative Medicines Division | 0 | 1967 |
| Jing Li | Co-President and Chief Executive Officer of Established Medicines Manufacturing & Supply Division | 0 | 1972 |
| Deyong Wen | Executive Vice Chairman | 9.71M | 1971 |
| Jia Yan | Chief Accountant, Co-CFO & Assistant to the President and Employee Director | 0 | 1982 |
| Jingzhu Cai | VP, Chief Investment Officer & GM of Global Strategic Investment Department | 0 | N/A |
| Mei Ha Kam FCIS | Joint Company Secretary | 0 | 1968 |
| Yue Zhu | Vice President & GM of Legal Department | 0 | 1977 |
| Xiang Li DPHIL | SVP, Co-President & CSO of the Innovative Drugs Business Unit | 0 | 1966 |
| Zhi Huang | Senior VP, CFO & Co-President of the Innovative Drugs Business Unit | 0 | N/A |
| Yuqing Chen | Executive Chairman | 0 | 1975 |
| Rongli Feng | Executive President & Chief Human Resources Officer | 0 | 1975 |
| Donghua Wang | Senior Vice President | 0 | 1969 |
| Kexin Wang | Executive Director | 0 | 1965 |
| Xiaohui Guan | Executive Co-Chairman | 0 | 1971 |
Description
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a comprehensive healthcare enterprise, operating across Mainland China and international markets. Its principal activities include the research, development, production, and commercialization of pharmaceutical products. The company focuses on significant therapeutic domains such as oncology, immunology, metabolic disorders, gastrointestinal health, and central nervous system conditions. In addition to its drug offerings, Fosun Pharma provides medical devices and diagnostic solutions. Its multifaceted operations are organized into five key segments: pharmaceutical manufacturing, medical devices and diagnostics, healthcare services, pharmaceutical distribution and retail, and other business initiatives. This scope extends to managing healthcare facilities and hospitals, as well as the wholesale and retail distribution of medicines. The company was founded in 1994 and is headquartered in Shanghai, China.
